Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophia Scheuermann

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nature Communications|November 4, 2018
Author Correction: The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradationAnnette Aichem, Samira Anders, Nicola Catone, et al.
Nature Communications|September 19, 2023
Translating genomic tools to Raman spectroscopy analysis enables high-dimensional tissue characterization on molecular resolutionManuel Sigle, Anne-Katrin Rohlfing, Martin Kenny, et al.
Journal of Translational Medicine|November 16, 2024
Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNETT Elise Potthoff, Carolin Walter, Daniela Jeising, et al.
Journal of Hematology & Oncology|July 29, 2025
Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricideBeate Kristmann, Niels Werchau, Lakshmi Suresh, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Frontiers in Immunology|August 9, 2021
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody TreatmentChristian Martin Seitz, Tim Flaadt, Markus Mezger, et al.
Leukemia|August 2, 2024
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemiaDaniel Atar, Lara Ruoff, Anna-Sophia Mast, et al.
Journal for Immunotherapy of Cancer|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohortAnna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.
Scientific Reports|April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approachJulia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2024
Macrophage Migration Inhibitory Factor Promotes Thromboinflammation and Predicts Fast Progression of Aortic StenosisKarin Anne Lydia Mueller, Carolin Langnau, Tobias Harm, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|November 4, 2018
Author Correction: The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradationAnnette Aichem, Samira Anders, Nicola Catone, et al.
Nature Communications|September 19, 2023
Translating genomic tools to Raman spectroscopy analysis enables high-dimensional tissue characterization on molecular resolutionManuel Sigle, Anne-Katrin Rohlfing, Martin Kenny, et al.
Journal of Translational Medicine|November 16, 2024
Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNETT Elise Potthoff, Carolin Walter, Daniela Jeising, et al.
Journal of Hematology & Oncology|July 29, 2025
Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricideBeate Kristmann, Niels Werchau, Lakshmi Suresh, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Frontiers in Immunology|August 9, 2021
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody TreatmentChristian Martin Seitz, Tim Flaadt, Markus Mezger, et al.
Leukemia|August 2, 2024
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemiaDaniel Atar, Lara Ruoff, Anna-Sophia Mast, et al.
Journal for Immunotherapy of Cancer|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohortAnna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.
Scientific Reports|April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approachJulia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2024
Macrophage Migration Inhibitory Factor Promotes Thromboinflammation and Predicts Fast Progression of Aortic StenosisKarin Anne Lydia Mueller, Carolin Langnau, Tobias Harm, et al.
Pageof 4